Dimensional Fund Advisors LP Bluebird Bio, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 603,874 shares of BLUE stock, worth $193,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

603,874

Previous 748,299 19.3%

Holding current value

$193,239

Previous $733,000 57.16%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$0.47 - $1.35 $67,879 - $194,973	-144,425 Reduced 19.3%	603,874 $314,000
Q2 2024 Aug 09, 2024	SELL	$0.85 - $1.26 $764,359 - $1.13 Million	-899,247 Reduced 54.58%	748,299 $733,000
Q1 2024 May 10, 2024	SELL	$0.91 - $1.75 $1.23 Million - $2.36 Million	-1,347,728 Reduced 45.0%	1,647,546 $2.11 Million
Q4 2023 Feb 07, 2024	BUY	$1.32 - $4.83 $1.72 Million - $6.31 Million	1,306,691 Added 77.38%	2,995,274 $4.13 Million
Q3 2023 Nov 09, 2023	BUY	$3.02 - $4.05 $917,364 - $1.23 Million	303,763 Added 21.94%	1,688,583 $5.13 Million
Q2 2023 Aug 09, 2023	SELL	$2.79 - $5.03 $3.38 Million - $6.09 Million	-1,211,649 Reduced 46.67%	1,384,820 $4.56 Million
Q1 2023 May 12, 2023	BUY	$3.14 - $8.22 $1.8 Million - $4.72 Million	573,662 Added 28.36%	2,596,469 $8.26 Million
Q4 2022 Feb 09, 2023	BUY	$5.77 - $8.49 $2.95 Million - $4.33 Million	510,524 Added 33.76%	2,022,807 $14 Million
Q3 2022 Nov 10, 2022	BUY	$3.75 - $7.39 $4.01 Million - $7.91 Million	1,070,006 Added 241.93%	1,512,283 $9.57 Million
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $609,276 - $1.08 Million	-207,237 Reduced 31.91%	442,277 $1.83 Million
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $796,275 - $2.07 Million	195,645 Added 43.11%	649,514 $3.15 Million
Q4 2021 Feb 09, 2022	BUY	$8.96 - $16.31 $1.04 Million - $1.9 Million	116,621 Added 34.58%	453,869 $4.54 Million
Q3 2021 Nov 12, 2021	BUY	$11.24 - $21.0 $637,746 - $1.19 Million	56,739 Added 20.23%	337,248 $6.45 Million
Q2 2021 Aug 12, 2021	SELL	$18.04 - $22.09 $304,208 - $372,503	-16,863 Reduced 5.67%	280,509 $8.97 Million
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $1.13 Million - $2.32 Million	-68,377 Reduced 18.7%	297,372 $8.96 Million
Q4 2020 Feb 25, 2021	BUY	$27.5 - $37.92 $10.1 Million - $13.9 Million	365,749 New	365,749 $15.8 Million

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Bluebird Bio, Inc. Transaction History